PSA After Neoadjuvant Androgen Suppression in Prostate Cancer Patients Receiving Short-Term Androgen Suppression and EBRT
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Prostate-Specific Antigen After Neoadjuvant Androgen Suppression in Prostate Cancer Patients Receiving Short-Term Androgen Suppression and External Beam Radiation Therapy: Pooled Analysis of Four NRG Oncology Radiation Therapy Oncology Group Randomized Clinical Trials
Int. J. Radiat. Oncol. Biol. Phys 2019 Aug 01;104(5)1057-1065, CL Hallemeier, P Zhang, TM Pisansky, GE Hanks, DG McGowan, M Roach, KL Zeitzer, SY Firat, SM Husain, DP D'Souza, L Souhami, MB Parliament, SA Rosenthal, HR Lukka, M Rotman, EM Horwitz, EF Miles, R Paulus, HM SandlerFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Advanced Prostate Cancer Center of Excellence
Visit our Advanced Prostate Cancer Center of Excellence for additional, in-depth coverage.